Community/Retail

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the reasons for the recent changes made to the American Geriatrics Society Beers Criteria.

Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.

The National Association of Chain Drug Stores Board of Directors, top executives from NACDS associate member companies and nationally recognized thought leaders will have a prime opportunity during December's NACDS Week in New York City to assess and anticipate highly consequential political and retail dynamics.